ACT featured Ed Ikeguchi’s predictions in a stand-alone piece, “The Defining AI Trends of 2022,” illustrating the importance of working collaboratively and strategically to advance the adoption of digital biomarkers and the development of unbiased AI in driving precision medicine to inform personalized care.
-
Share
-
Recent Press
-
Jul 29, 2026
AICure Expands Executive Leadership to Accelerate AI-Powered Medication Adherence, Remote Weight Verification, and Enterprise White-Label Solutions
-
Jul 21, 2026
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
-
May 29, 2025
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
-
Jul 29, 2026